(Q38501928)

3 September 2017

0 references

1 reference

title

Enamel matrix derivative and bone grafts for periodontal regeneration of intrabony defects. A systematic review and meta-analysis (English)

1 reference

3 September 2017

1 reference

enamel matrix derivative

1 reference

1 reference

M Matarasso

1

1 reference

3 September 2017

V Iorio-Siciliano

2

1 reference

3 September 2017

A Blasi

3

1 reference

3 September 2017

L Ramaglia

4

1 reference

3 September 2017

G E Salvi

5

1 reference

3 September 2017

A Sculean

6

1 reference

3 September 2017

publication date

27 May 2015

1 reference

Clinical Oral Investigations

3 September 2017

published in

1 reference

3 September 2017

volume

19

1 reference

3 September 2017

issue

7

1 reference

3 September 2017

page(s)

1581-1593

1 reference

3 September 2017

cites work

Periodontal diseases.

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

Biomaterials for promoting periodontal regeneration in human intrabony defects: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

Periodontal regeneration with enamel matrix derivative in reconstructive periodontal therapy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

Healing, post-operative morbidity and patient perception of outcomes following regenerative therapy of deep intrabony defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

Focus on intrabony defects: guided tissue regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

Enamel matrix proteins in the regenerative therapy of deep intrabony defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

Enamel matrix derivative, alone or associated with a synthetic bone substitute, in the treatment of 1- to 2-wall periodontal defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

Clinical outcomes following regenerative therapy of non-contained intrabony defects using a deproteinized bovine bone mineral combined with either enamel matrix derivative or collagen membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

Effects of enamel matrix proteins in combination with a bovine-derived natural bone mineral for the repair of bone defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

Autogenous bone graft in conjunction with enamel matrix derivative in the treatment of deep periodontal intra-osseous defects: a report of 13 consecutively treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

The use of bovine porous bone mineral in combination with enamel matrix proteins or with an autologous fibrinogen/fibronectin system in the treatment of intrabony periodontal defects in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

Enamel matrix proteins and bovine porous bone mineral in the treatment of intrabony defects: a comparative controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

Clinical and radiographic outcomes of the modified minimally invasive surgical technique with and without regenerative materials: a randomized-controlled trial in intra-bony defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

Healing of human intrabony defects following regenerative periodontal therapy with an enamel matrix protein derivative alone or combined with a bioactive glass. A controlled clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

Primary flap closure combined with Emdogain alone or Emdogain and Cerasorb in the treatment of intra-bony defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

A guide to systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

Effect of Autogenous Cortical Bone Particulate in Conjunction With Enamel Matrix Derivative in the Treatment of Periodontal Intraosseous Defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-015-1491-7

Which biomaterials may promote periodontal regeneration in intrabony periodontal defects? A systematic review of preclinical studies

21 January 2018

1 reference

12 December 2020

Enamel matrix derivative alone or in combination with a bioactive glass in wide intrabony defects

1 reference

12 December 2020

Periodontal regeneration of human intrabony defects. IV. Determinants of healing response

1 reference

12 December 2020

Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass

1 reference

12 December 2020

Enamel matrix derivative in combination with bone grafts: A review of the literature

1 reference

12 December 2020

Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial

1 reference

12 December 2020

Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate

1 reference

12 December 2020

A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans

1 reference

12 December 2020

Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans

1 reference

12 December 2020

Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans

1 reference

12 December 2020

Enamel matrix derivative (Emdogain®) for periodontal tissue regeneration in intrabony defects

1 reference

12 December 2020

Comparative study of DFDBA in combination with enamel matrix derivative versus DFDBA alone for treatment of periodontal intrabony defects at 12 months post-surgery

1 reference

12 December 2020

Clinical evaluation of demineralized freeze-dried bone allograft with and without enamel matrix derivative for the treatment of periodontal osseous defects in humans

1 reference

12 December 2020

Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative combined with a bovine-derived xenograft

1 reference

12 December 2020

A multi-centre randomized controlled clinical trial on the treatment of intra-bony defects with enamel matrix derivatives/synthetic bone graft or enamel matrix derivatives alone: results after 12 months

1 reference

12 December 2020

Comparison of infrabony defects treated with enamel matrix derivative versus guided tissue regeneration with a nonresorbable membrane

1 reference

12 December 2020

Clinical outcomes after treatment of intra-bony defects with an EMD/synthetic bone graft or EMD alone: a multicentre randomized-controlled clinical trial

1 reference

12 December 2020

Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral.

1 reference

12 December 2020

10.1007/S00784-015-1491-7

Identifiers

DOI

1 reference

3 September 2017

1 reference